Home

Offre demploi traversier silence event free survival overall Agresser Mentalité Rejeter

Wilms tumour event-free and overall survival in Southern and Eastern  Europe: Pooled analyses of clinical data from four childhood cancer  registries (1999–2017) - European Journal of Cancer
Wilms tumour event-free and overall survival in Southern and Eastern Europe: Pooled analyses of clinical data from four childhood cancer registries (1999–2017) - European Journal of Cancer

Event-Free Survival As a Surrogate Endpoint for Overall Survival in  Previously Untreated Acute Myeloid Leukemia: An Individual Patient-Level  Analysis of Multiple Randomized Trials (Alliance A151614) - ScienceDirect
Event-Free Survival As a Surrogate Endpoint for Overall Survival in Previously Untreated Acute Myeloid Leukemia: An Individual Patient-Level Analysis of Multiple Randomized Trials (Alliance A151614) - ScienceDirect

A prognostic nomogram for event-free survival in patients with atrial  fibrillation before cardiac resynchronization therapy | BMC Cardiovascular  Disorders | Full Text
A prognostic nomogram for event-free survival in patients with atrial fibrillation before cardiac resynchronization therapy | BMC Cardiovascular Disorders | Full Text

High rate of event-free survival at 24 months with everolimus/RCHOP for  untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085  (Alliance) | Blood Cancer Journal
High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance) | Blood Cancer Journal

Relationship between presarcopenia and event occurrence in patients with  primary hepatocellular carcinoma | Scientific Reports
Relationship between presarcopenia and event occurrence in patients with primary hepatocellular carcinoma | Scientific Reports

Identification of potential surrogate end points in randomized clinical  trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of  complete response, time-to-event and overall survival end points - Annals  of Oncology
Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points - Annals of Oncology

JCI - Umbilical cord blood expansion with nicotinamide provides long-term  multilineage engraftment
JCI - Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment

Blood and tissue biomarker analysis in dogs with osteosarcoma treated with  palliative radiation and intra-tumoral autologous natural killer cell  transfer | PLOS ONE
Blood and tissue biomarker analysis in dogs with osteosarcoma treated with palliative radiation and intra-tumoral autologous natural killer cell transfer | PLOS ONE

Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival  as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal  Adenocarcinoma
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma

Event-free Survival with Pembrolizumab in Early Triple-Negative Breast  Cancer | NEJM
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer | NEJM

A) Event-free survival (EFS), (B) disease-free survival (DFS), and (C)... |  Download Scientific Diagram
A) Event-free survival (EFS), (B) disease-free survival (DFS), and (C)... | Download Scientific Diagram

Acute myeloid leukemia: survival analysis of patients at a university  hospital of Paraná | Hematology, Transfusion and Cell Therapy
Acute myeloid leukemia: survival analysis of patients at a university hospital of Paraná | Hematology, Transfusion and Cell Therapy

Surrogate endpoints for overall survival in locally advanced head and neck  cancer: meta-analyses of individual patient data - The Lancet Oncology
Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data - The Lancet Oncology

Event-Free Survival, a Prostate-Specific Antigen–Based Composite End Point,  Is Not a Surrogate for Overall Survival in Men With Localized Prostate  Cancer Treated With Radiation | Journal of Clinical Oncology
Event-Free Survival, a Prostate-Specific Antigen–Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation | Journal of Clinical Oncology

New Prediction Model for 5-year Event-free Survival Rate from Ventricular  Arrhythmia | Radcliffe Cardiology
New Prediction Model for 5-year Event-free Survival Rate from Ventricular Arrhythmia | Radcliffe Cardiology

Kaplan-Meier curve for overall survival (OS) and event-free survival (EFS)  according to the expression of CD30 and IPI.
Kaplan-Meier curve for overall survival (OS) and event-free survival (EFS) according to the expression of CD30 and IPI.

Relationship between event-free survival and overall survival in acute  myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI |  Haematologica
Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI | Haematologica

A correlation analysis to assess event-free survival as a trial-level  surrogate for overall survival in early breast cancer - eClinicalMedicine
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine

Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival  as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal  Adenocarcinoma
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma

Fig. 72.1, [Four-year event-free survival (EFS), overall...]. - The EBMT  Handbook - NCBI Bookshelf
Fig. 72.1, [Four-year event-free survival (EFS), overall...]. - The EBMT Handbook - NCBI Bookshelf